Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii

We retrospectively analyzed the effect of tigecycline and cefoperazone/sulbactam therapies on the prognosis of patients with carbapenem-resistant Acinetobacter baumannii bloodstream infection (CRAB-BSI). CRAB-BSI patients receiving tigecycline therapy or cefoperazone/sulbactam therapy between Januar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tianshui Niu, Qixia Luo, Yaqing Li, Yanzi Zhou, Wei Yu, Yonghong Xiao
Format: Artigo
Idioma:anglès
Publicat: 2019
Accés en línia:https://doi.org/10.1186/s13756-019-0502-x
https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-019-0502-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!